Lapatinib Ditosylate Powder: Advanced Anticancer Agent for Targeted Therapy
Potent dual tyrosine kinase inhibitor for HER2-positive breast cancer and solid tumors.
Get a Quote & SampleProduct Core Value
Lapatinib Ditosylate Powder
Lapatinib Ditosylate powder is a synthetic, orally-active quinazoline with potent antineoplastic activity. It functions as a dual tyrosine kinase inhibitor, effectively blocking the phosphorylation of EGFR and ErbB2 (HER2/neu) pathways. This makes it a critical component in the treatment of various cancers, particularly HER2-positive breast cancer.
- Discover the power of targeted cancer therapy with Lapatinib Ditosylate Powder, a key pharmaceutical intermediate.
- Explore the benefits of this orally active quinazoline, a crucial tool in combating HER2-positive breast cancer.
- Benefit from high purity (>99%) Lapatinib Ditosylate powder, ensuring efficacy and reliability in your formulations.
- Leverage the potential of tyrosine kinase inhibitors with our competitively priced Lapatinib Ditosylate powder, available for purchase.
Key Advantages
Targeted Pathway Inhibition
Effectively inhibits EGFR and HER2/neu pathways, offering precise action against cancer cell growth, crucial for HER2 positive breast cancer treatment.
Oral Bioavailability
As an orally active quinazoline, it provides a convenient administration route, enhancing patient compliance and treatment adherence for anticancer drug regimens.
High Purity & Quality Assurance
Our Lapatinib Ditosylate powder boasts over 99% purity and is manufactured under strict quality standards (GMP, ISO 9001), ensuring consistent performance as a pharmaceutical intermediate.
Key Applications
Oncology Drug Development
A vital pharmaceutical intermediate used in the synthesis of advanced anticancer agents, particularly those targeting tyrosine kinase pathways.
HER2-Positive Breast Cancer Therapy
Essential for formulating treatments for HER2-positive breast cancer, contributing to improved patient outcomes by inhibiting key oncogenic drivers.
Solid Tumor Treatments
Investigated and utilized in the treatment of various solid tumors where EGFR and HER2/neu overexpression is a contributing factor.
Tyrosine Kinase Inhibitor Research
A valuable research chemical for scientists studying the mechanisms of tyrosine kinase inhibitor action and developing novel cancer therapies.